Carisma Therapeutics Banner Image

Carisma Therapeutics

  • Ticker CARM
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Carisma Therapeutics Logo Image
  • 11-50 Employees
  • Based in Philadelphia, Pennsylvania
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Their technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
3.5 / 5.0 (4)

Carisma Therapeutics reports have an aggregate usefulness score of 3.5 based on 4 reviews.

Carisma Therapeutics

Most Recent Annual Report

Carisma Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Carisma Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!